mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Mostrar otras versiones (1)

Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529) harboring up to 36 mutations in spike protein, the target of vaccine-induced neutralizing antibodies. Given its potential to escape vaccine-induced humoral immunity, we measured neutralization potency o...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Beltran, Wilfredo F., St. Denis, Kerri J., Hoelzemer, Angelique, Lam, Evan C., Nitido, Adam D., Sheehan, Maegan L., Berrios, Cristhian, Ofoman, Onosereme, Chang, Christina C., Hauser, Blake M., Feldman, Jared, Gregory, David J., Poznansky, Mark C., Schmidt, Aaron G., Iafrate, A. John, Naranbhai, Vivek, Balazs, Alejandro B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687472/
https://www.ncbi.nlm.nih.gov/pubmed/34931201
http://dx.doi.org/10.1101/2021.12.14.21267755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687472/
https://www.ncbi.nlm.nih.gov/pubmed/34931201
http://dx.doi.org/10.1101/2021.12.14.21267755

Ejemplares similares